A traditional Chinese medicine composition for infectious disease recovery, containing the Chinese medicinal herbs: 2-4 parts of ginseng, 4-8 parts of Ophiopogon japonicus, 2-4 parts of Schisandra chinensis berry, 6-10 parts of Wolfiporia extensa Ginns, 6-10 parts of rhizoma pinelliae, 4-8 parts of Scrophularia ningpoensis, 4-6 parts of stir-fried Atractylodes, 4-8 parts of mandarin orange peel, 2-4 parts of Glycyrrhiza uralensis, 4-8 parts of Bupleurum scorzonerifolium, 2-4 parts of Actaea cimicifuga, 8-12 parts of Coix lacryma-jobi, 8-12 parts of Scutellaria baicalensis, 8-12 parts of Verbena officinalis, 12-18 parts of rhizoma phragmitis, and 1-3 parts of Lophatherum gracile. The present traditional Chinese medicine composition can be used in medicines for the prevention, treatment, or alleviation of the sequelae or complications of infectious diseases or for the promotion of the functional recovery of damaged tissues, organs or systems caused by infectious diseases.

The present invention relates to a composition containing a Pinelliae Rhizoma and Scutellariae Radix extract as an active ingredient to reduce side effects caused by an anticancer drug, and more particularly, a composition for reducing side effects such as damage to the gastrointestinal tract and a gastrointestinal motility disorder by administering an anticancer drug. The composition of the present invention has an excellent effect of reducing side effects in administration of the anticancer drug through an antioxidative function, and synthesis, secretion and control of the functions of gastrin and serotonin producing gastrointestinal endocrine cells.

The present invention relates to a composition containing a Pinelliae Rhizoma and Scutellariae Radix extract as an active ingredient to reduce side effects caused by an anticancer drug, and more particularly, a composition for reducing side effects such as damage to the gastrointestinal tract and a gastrointestinal motility disorder by administering an anticancer drug. The composition of the present invention has an excellent effect of reducing side effects in administration of the anticancer drug through an antioxidative function, and synthesis, secretion and control of the functions of gastrin and serotonin producing gastrointestinal endocrine cells.

The present invention relates to a composition containing a Pinelliae Rhizoma and Scutellariae Radix extract as an active ingredient to reduce side effects caused by an anticancer drug, and more particularly, a composition for reducing side effects such as damage to the gastrointestinal tract and a gastrointestinal motility disorder by administering an anticancer drug. The composition of the present invention has an excellent effect of reducing side effects in administration of the anticancer drug through an antioxidative function, and synthesis, secretion and control of the functions of gastrin and serotonin producing gastrointestinal endocrine cells.

The present invention provides an application of a combination of traditional Chinese medicine in the preparation of a potassium ion channel modulating agent. The combination of traditional Chinese medicine is made up of traditional Chinese medicine raw materials according to the following weight proportion:

TABLE-US-00001 Coptidis Rhizoma 250~450 Sophorae Flavescentis 150~350 Radix Pinelliae Rhizoma 150~350 Artemisiae Annuae Herba 150~350 Poria 150~450 Ginseng Radix Et Rhizoma 65~265 Aurantii Fructus 65~265 Ophiopogonis Radix 150~350 Immaturus Dichroae Radix 150~350 Glycyrrhizae Radix Et 65~265 Nelumbinis Plumula 10~70 Rhizoma

The combination of traditional Chinese medicine of the present invention could prolong the action potential interval of the myocardial cells, thereby prolong the refractory period of myocardial electrical activity. It has the function of inhibiting arrhythmia induced by excitatory reentry without toxic side effects. The invention provides a new medicine for the treatment of ventricular, atrial or ventricular arrhythmias, and it has a good application prospect. The invention is easy to be operated and suitable for large-scale production.

The present invention provides an application of a combination of traditional Chinese medicine in the preparation of a potassium ion channel modulating agent. The combination of traditional Chinese medicine is made up of traditional Chinese medicine raw materials according to the following weight proportion:

TABLE-US-00001 Coptidis Rhizoma 250~450 Sophorae Flavescentis 150~350 Radix Pinelliae Rhizoma 150~350 Artemisiae Annuae Herba 150~350 Poria 150~450 Ginseng Radix Et Rhizoma 65~265 Aurantii Fructus 65~265 Ophiopogonis Radix 150~350 Immaturus Dichroae Radix 150~350 Glycyrrhizae Radix Et 65~265 Nelumbinis Plumula 10~70 Rhizoma

The combination of traditional Chinese medicine of the present invention could prolong the action potential interval of the myocardial cells, thereby prolong the refractory period of myocardial electrical activity. It has the function of inhibiting arrhythmia induced by excitatory reentry without toxic side effects. The invention provides a new medicine for the treatment of ventricular, atrial or ventricular arrhythmias, and it has a good application prospect. The invention is easy to be operated and suitable for large-scale production.

The present invention relates to a composition for treating, improving, or preventing Alzheimer's disease caused by ApoE4 gene mutation, the composition including Banha-Sasim-Tang as an active ingredient.

The composition including Banha-Sasim-Tang as an active ingredient of the present invention and a treatment method exhibit excellent effects of reducing amyloid beta proteins and inhibiting deposition thereof, which are specific to Alzheimer's disease caused by ApoE4 gene mutation, thereby having high applicability as a specific composition for preventing, improving, or treating Alzheimer's disease caused by ApoE4 gene mutation.

The present invention relates to a composition for treating, improving, or preventing Alzheimer's disease caused by ApoE4 gene mutation, the composition including Banha-Sasim-Tang as an active ingredient.

The composition including Banha-Sasim-Tang as an active ingredient of the present invention and a treatment method exhibit excellent effects of reducing amyloid beta proteins and inhibiting deposition thereof, which are specific to Alzheimer's disease caused by ApoE4 gene mutation, thereby having high applicability as a specific composition for preventing, improving, or treating Alzheimer's disease caused by ApoE4 gene mutation.

The present invention relates to a composition for treating, improving, or preventing Alzheimer's disease caused by ApoE4 gene mutation, the composition including Banha-Sasim-Tang as an active ingredient.

The composition including Banha-Sasim-Tang as an active ingredient of the present invention and a treatment method exhibit excellent effects of reducing amyloid beta proteins and inhibiting deposition thereof, which are specific to Alzheimer's disease caused by ApoE4 gene mutation, thereby having high applicability as a specific composition for preventing, improving, or treating Alzheimer's disease caused by ApoE4 gene mutation.

The present invention relates to a pharmaceutical composition for healing abdominal pain and flatulence. The pharmaceutical composition comprises a combination of herbal components, which serve as active ingredients. The herbal components in the composition are Poria cocos, Atractylodes macrocephala, Paeonia lactiflora, Pseudostellaria heterophylla, Pogostemon cablin, Citrus reticulata, Amomum villosum, Evodia rutaecarpa, Alpinia officinarum, Zingiber officinale, Astragalus membranaceus, Dioscorea opposite, Angelica dahurica, Panax ginseng, Corydalis yanhusuo, Glycyrrhiza uralensis, Cyperus rotundus, Hordeum vulgare, Lindera aggregate, Melia toosendan, Pinellia ternate, Foeniculum vulgare, Elettaria cardamomum, Curcuma longa, Atractylodes lancea, Triticum aestivum, and Mentha x piperita.